​

Funding Round

Series B - MiroBio

Series B - MiroBio

Investment Firm

Overview

MiroBio is Harnessing the natural control mechanisms of the immune system.

Announced Date

Jun 29, 2022

Funding Type

Series B

Highlights

Location

Europe

Social

Investor Lead

Medicxi

Medicxi

Medicxi is a early_stage_venture and seed firm.

Participant Investors

6

Investor Name
Participant InvestorOrbiMed
Participant InvestorSR One
Participant InvestorOxford Science Enterprises
Participant InvestorMedicxi
Participant InvestorAdvent Life Sciences

Round Details and Background

MiroBio raised $97033798 on 2022-06-29 in Series B

MiroBio is Harnessing the natural control mechanisms of the immune system.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Oct 07, 2019
Series A - MiroBio
4-33.2M
Jun 29, 2022
Series B - MiroBio
7-97.0M

Recent Activity

There is no recent news or activity for this profile.